1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Epithelioid Sarcoma (ES): new trials by email Literature Review of Epithelioid Sarcoma (ES) trials Research Report on Epithelioid Sarcoma (ES)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels Tazemetostat, Itraconazole, Rifampin - All Malignancies, Advanced Malignancies | Phase 1 | Completed | Epizyme, Inc. | 42 | 2020-04-23 | 2025-02-19 |
| A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study Tazemetostat - Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) | Phase 1 / Phase 2 | Terminated | Epizyme, Inc. | 58 | 2016-08-30 | 2026-10-28 |
Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Non-Hodgkin (2) · Mesothelioma (2) · Sarcoma (2) · Sarcoma, Synovial (2) · Hematologic Neoplasms (1) · Rhabdoid Tumor (1)
Adenoma (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, B-Cell (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Mesothelial (2) · Hematologic Diseases (1)
tazemetostat (2) · Itraconazole (1) · Rifampin (1)
Epizyme, Inc. (2)
United States (2) · Australia (1) · Belgium (1) · France (1) · Poland (1) · Spain (1) · Ukraine (1) · United Kingdom (1)
2015 (1), 2023 (1)